ABSTRACT'. Serum thyroglobulin (Tg) measurements were performed in 17 children with congenital hypothyroidism due to an ectopic thyroid gland before therapy and during follow-up. Data were analysed in four periods according to duration of therapy and compared to results obtained in a group of 51 normal children aged 1 month to 6 yr. At diagnosis serum Tg was higher than the mean normal value measured at a similar age. We observed a rapid and parallel decrease of both Tg and thyroid-stimulating hormone during the early weeks of therapy. However, Tg was always detectable in the serum of treated (euthyroid) patients. After 34 months of therapy serum Tg was 11.4 f 1 ng/ml, a value significantly different (p < 0.001) from that obtained in normal controls of similar age (23.5 f 3 ng/ml). In nine treated children aged more than 2 yr, thyroid-stimulating hormone and Tg were increased after a brief period of decreased L-thyroxine dosage. Tg is secreted by the thyroid gland and its presence in the serum indicates that some thyroid tissue is present (1). In patients with congenital hypothyroidism there is a good correlation between the presence of thyroid tissue and the presence of Tg in serum. Infants with athyreosis have undetectable serum Tg, whereas in those with thyroid tissue as demonstrated by thyroid scanning, Tg is present in serum (2, 3). In a group of patients with congenital hypothyroidism and remnant thyroid tissue, the mean Tg value was higher than normal values for age (3). Tg secretion is subject to TSH control. In normal subjects, suppression of pituitary TSH release by T3 decreases serum Tg levels (4), whereas TSH stimulation by TRH increases serum Tg levels (5). Thus, elevated serum Tg values observed in some patients with ectopic gland may be due to over stimulation by TSH of remnant tissue. 
Tg, thyroglobulin TSH, thyroid stimulating hormone T3, triiodothyronine TRH, thyrotropin releasing hormone T4, thyroxine FT4, free T4 RIA, radioimmunoassay Tg is secreted by the thyroid gland and its presence in the serum indicates that some thyroid tissue is present (1) . In patients with congenital hypothyroidism there is a good correlation between the presence of thyroid tissue and the presence of Tg in serum. Infants with athyreosis have undetectable serum Tg, whereas in those with thyroid tissue as demonstrated by thyroid scanning, Tg is present in serum (2, 3) . In a group of patients with congenital hypothyroidism and remnant thyroid tissue, the mean Tg value was higher than normal values for age (3) . Tg secretion is subject to TSH control. In normal subjects, suppression of pituitary TSH release by T3 decreases serum Tg levels (4), whereas TSH stimulation by TRH increases serum Tg levels (5) . Thus, elevated serum Tg values observed in some patients with ectopic gland may be due to over stimulation by TSH of remnant tissue.
Herein we measured serum Tg during the period of early treatment and control of the hypothyroid state and also later, after a short period of decreased thyroxine dosage. Our results indicate that Tg secretion by the ectopic gland is under the control of TSH and resembles that observed in the normal gland. Detectable serum Tg in treated (euthyroid) patients suggests that some thyroid hormone secretion occurs even in patients in good control and after a long period of treatment.
PATIENTS AND PROTOCOL
A group of 17 children with ectopic thyroid glands was enrolled in this study. They were selected from a cohort of patients with congenital hypothyroidism on the basis of the radioiodine uptake [Iz3I] and the presence of measurable serum Tg. All had measurable Tg levels when evaluated during the first weeks of life, before L-thyroxine replacement therapy. Treatment usually was initiated before 1 month of age (range 20-45 days, mean f SEM 27 f 2 days) and the patients were seen at regular intervals for evaluation. Sera for Tg measurements were kept at -20" C until assay. Data were grouped in four periods according to the timing of thyroxine therapy-2 wk to 2 months, 2 to 10 months, 10 to 34 months, and more than 34 months.
In a separate group of nine patients (with ectopic glands) who had received adequate thyroxine therapy for more than 2 yr, the effect of a decrease of T4 dosage on the serum Tg levels was analyzed. All patients had measurable Tg levels when assayed at 1 month of age before beginning therapy. Serum Tg, TSH, and FT4 were measured during adequate T4 therapy (period A) and after 6 wk of (50%) reduced thyroxine dosage (period B). Informed consent was obtained from the parents for this second protocol.
A group of 51 children aged 1 month to 6 yr, entering the department of pediatric surgery for minor operations, served as controls. Blood (2 ml) was taken at least 1 day before surgery at the time of routine laboratory studies after consent of the parents was obtained.
METHODS
Serum Tg was measured by RIA using the method of Van Herle et al. (4) . The lower limit of sensitivity was 2.5 ng/ml. The presence of circulating Tg antibodies was ruled out by the tanned red cell agglutination technique (Burroughs-Wellcome Research, Triangle Park, NC). Serum T4, FT4, and TSH concentrations were measured by RIA using commercial kits. As indicated, TSH was measured by two techniques. The RIA technique was used for the first part of the study, whereas an immunoradiometric assay (6) was used for the second part of the study concerning variation of the thyroxine treatment dosage in older children.
All data are reported as mean f SEM. Statistical comparisons 267 were made by Student's paired and unpaired t tests, or by linear regression analysis.
RESULTS
Serum T4, T3, TSH, and Tg levels at the time of diagnosis are shown in Figure 1 . The mean serum Tg was higher than the mean normal value measured at a similar age although this difference was not significant (98.3 a 32.8 versus 55.3 2 6.7 ng/ ml). Before treatment no correlation was found between Tg and TSH, T4, or T3.
Mean values for serum Tg and TSH levels in treated patients for the several treatment intervals are shown in Table 1 and are represented in percent of initial value in Figure 2 . Serum T4 increased with treatment and mean values remained in the high normal range. It can be seen that TSH decreased rapidly and became normal after 2 months of therapy. A parallel decrease in serum Tg was observed although the rate of decline was slower than the fall of serum TSH. After 2 months of therapy the mean serum Tg level was significantly lower than the mean value of normal control children. Serum Tg remained detectable in the serum of treated children at all treatment intervals.
The data concerning reduction of thyroxine dosage in older treated children are shown in Figure 3 . A significant fall in serum FT4 was observed (from 24 + 1.9 to 16 + 0.6 ng/l, p < 0.0 1). Serum TSH increased during the same period (from 5.3 + 1.8 to 39 + 7 pU/ml, p < 0.01) and there was an increase in serum Tg from 13.2 + 1.5 to 24.1 + 4 ng/ml ( p < 0.05). There was no correlation between the magnitude of the decrease in serum T4 and the rise in serum TSH or the rise of serum Tg.
DISCUSSION
The aim of this investigation was to assess the changes in serum Tg in a group of infants with ectopic thyroid glands during treatment. The mean serum Tg level was elevated above the normal value for age at the time of diagnosis although the elevation was not significant. 
*Treatment was initiated before 1 month of age. After this period age and duration of treatment were considered to be identical.
t FT4 (ng/l) = 23 + 1.5 (n = 13). trations. Although serum Tg was relatively decreased during thyroxine therapy it was never totally suppressed.
In a separate group of children, a transient 50% decrease in daily thyroxine dosage was instituted. In this situation the serum FT4 level decreased, and serum TSH increased. The mean serum Tg level increased significantly indicating the presence of responsive thyroid tissue. This result indicated that the residual ectopic thyroid tissue in these children can be stimulated when TSH is moderately elevated in the serum. In a study by Job et al. (7) the residual ectopic tissue in children with congenital hypothyroidism was sequentially studied by radioiodine uptake 1.5 to 3.5 yr after diagnosis. On the basis of a progressive decline of iodine uptake these investigations concluded that there is a progressive involution of thyroid tissue. On the basis of our serum Tg measurements herein we reach a different conclusion.
As previously reported by several investigators (2, 3, 8, 9) serum Tg is elevated in patients with ectopic thyroid glands. The exact mechanisms for this high serum Tg is not clear. Serum Tg levels are related to several factors. The first is the concentration of circulating TSH. Serum TSH is elevated in the case of primary congenital hypothyroidism and probably is the primary factor responsible for the high serum Tg level (10, 11) . However, we did not observe a significant correlation between the serum TSH and Tg levels in our children and such a correlation might be expected if TSH was the principal cause of the elevated serum Tg. Other mechanisms should also be considered including the metabolic clearance rate of Tg and the rate of secretion by the thyroid gland. A decreased clearance of Tg may explain a high serum Tg level in hypothyroidism, but to our knowledge there are no data available on this point and we conducted no measurements of Tg clearance. Herein, an increased rate of secretion by an ectopic tissue remnant remains a possible cause. It has been shown in patients with nontoxic goiter (12) , in some cases of thyroiditis (13) , and in some patients with benign and malignant thyroid tumors (14) that increased serum Tg levels may be observed in the absence of an elevated serum TSH. In this situation an increased rate of secretion of Tg by an abnormal tissue may be involved. A similar mechanism may operate in children with ectopic tissue. Furthermore it has been shown in premature neonates that serum Tg is elevated compared to term infants (15) . One might speculate that the ectopic glands in our patients remained in a fetal state. Finally our findings may reflect abnormal secretion by dystrophic tissue or an abnormal developmental process in the ectopic glands. Although histological descriptions of these glands are scarce, available data show that tissue of ectopic thyroid is abnormal and dysplasic (1 6-1 8).
The decline of serum Tg during treatment is at least partly due to the decrease in serum TSH concentration. However, a gradual decline in Tg secretion also is observed during the first year of life in normal children (1 9) . The extent to which our observations in hypothyroid infants reflect this normal process of progressive decline in serum Tg remains speculative. At the end of the first year of treatment and thereafter the mean serum Tg level was lower than the value in normal controls. The persistence of measurable serum Tg in treated patients suggests that thyroid secretion occurs to some extent in patients with treated congenital hypothyroidism (athyreosis excluded because of undetectable Tg level in these patients (2, 3, 8, 9) . It has been shown that when thyroid tissue is totally suppressed the serum Tg level falls to undetectable levels. This can be demonstrated in patients with thyrotoxicosis factitia (20) in which cases complete suppression of thyroid function is associated with undetectable serum TSH levels, low radioiodine uptake, and undetectable serum Tg concentrations.
The situation is rather different in our group of patients. During the course of thyroxine therapy, dosage was adjusted to maintain serum TSH levels in a normal range, and the serum TSH level in these children was never undetectable. The ectopic tissue was therefore continuously stimulated, presumably accounting for the persistant measurable Tg serum levels. The concept of functioning remnant thyroid tissue is further emphasized by the secondary rise in serum Tg observed when the thyroxine replacement dose was reduced. This increase in serum Tg indicates that thyroid tissue was present in these children and, when stimulated, can secrete more Tg and possibly T4. Our results indicate that the serum Tg measurement can be a useful tool to evaluate residual thyroid function in patients with congenital hypothyroidism after treatment.
